We investigated the cause of autosomal recessive nonsyndromic hearing loss (ARNSHL) that segregated in 2 consanguineous Iranian families. Methods: Otologic and audiometric examinations were performed on affected members of each family. Genome-wide parametric multipoint linkage mapping using a recessive model was performed with Affymetrix 50K GeneChips or short tandem repeat polymorphisms. Direct sequencing was used to confirm the causative mutation in each family. Results: In 2 Iranian families, L-1651 and L-8600606, with ARNSHL that mapped to the DFNB7/11 locus, homozygosity for a reported splice site mutation (c.776+1G>A), and a novel deletion (c.1589_1590delCT; p.S530*) were identified in the TMC1 gene, respectively. Conclusions: Consistent with the previously reported phenotype in DFNB7/11 families, the 2 Iranian families had segregated congenital, profound hearing impairment. However, in family L-1651, one affected family member (IV:3) has milder hearing impairment than expected, suggesting a potential genetic modifier effect. These results indicate that DFNB7/11 is a common form of genetic hearing loss in Iran, because this population is the source of 6 of the 29 TMC1 mutations reported worldwide.
INTRODUCTION
Hearing impairment is a common and genetically heterogeneous sensory disorder. Recessively inherited deafness accounts for approximately 80% of cases of genetic hearing loss. To date, 34 genes and 85 genetic loci have been implicated in autosomal recessive nonsyndromic hearing loss (ARNSHL). 1 Most of these ARNSHL genes have been identified by linkage analysis of consanguineous families with ARNSHL.
Mutations in the TMC1 gene at the DFNB7/11 locus on chromosome 9q31-21 are a common cause of ARNSHL. To date, 30 recessive mutations have been reported in 48 families worldwide. [2] [3] [4] [5] [6] [7] [8] [9] [10] This number makes DFNB7/11 the sixth-most-common cause of ARNSHL. 11 TMC1 has also been implicated in ARNSHL at the DFNA36 locus; however, this type of hearing loss is much less common, with only 3 mutations reported. 2, 9, 12, 13 Recessive mutations in TMC1 lead to congenital and profound hearing loss, whereas dominant mutations are associated with progressive hearing loss that initially affects the high frequencies. 9 The function of the transmembrane channel-like 1 (TMC1) protein in the inner ear is unknown, although its expression localizes to outer hair cells of the mouse inner ear after P3. 14 Tmc1 deficiency in the recessive mouse mutant dn triggers hair cell degeneration and leads to profound hearing loss, whereas semidominance for the Tmc1 p.M412K allele in the heterozygous Bth mutant causes progressive hearing loss, consistent with the genotype-phenotype correlations observed in human patients. 14, 15 In this study, we report genetic and phenotypic analyses of 2 consanguineous Iranian families with ARNSHL. A novel deletion, a previously reported splice site mutation, and a potential genetic modifier effect are identified and described in these families. This report provides further evidence that mutations at the DFNB7/11 loci are a frequent cause of ARNSHL.
MATERIALS AND METHODS
Families. Families L-1651 and L-8600606 are consanguineous Iranian families with ARNSHL ( Fig 1) . Audiological testing was completed to document the degree of hearing loss in all affected family members (Fig 2) . Vestibular dysfunction and a syndromic presentation were excluded through examination by an otolaryngologist and a clinical geneticist.
All participating family members gave written informed consent. Ten milliliters of whole blood were obtained from each family member by venipuncture, and genomic DNA was extracted as described previously. 16 Human research Institutional Review Boards at the Welfare Science and Rehabilitation University and the Iran University of Medical Sciences, Tehran, Iran, and the University of Iowa, Iowa City, Iowa, approved all procedures.
Single Nucleotide Polymorphism Genotyping and
Linkage Analysis of Family L-1651. Genomic DNA from individuals III:2, IV:1, IV:2, IV:3, IV:4, IV:5, V:1, and V:2 in family L-1651 ( Fig 1) was geno-typed for 50,000 single nucleotide polymorphisms (SNPs) with Affymetrix 50k Xba GeneChips at the Translational Genomics Research Institute (TGEN, Phoenix, Arizona). Genotypes were determined with the BRLMM (Bayesian robust linear model Mahalanobis) genotyping algorithm. 13, 14 A subset of 7,993 SNPs with high heterozygosity spaced approximately 0.3 cM apart across the genome was chosen from the 50k Xba set to satisfy the linkage equilibrium requirements of the Lander-Green algorithm for multipoint linkage analysis. 17 Selection and assembly of the data files were performed with Linkdatagen (http://bioinf.wehi.edu.au/software). 17 Mendelian inheritance errors were identified and removed with Linkdatagen, and Merlin 16 was used to remove genotyping errors identified on the basis of inferred double recombination events between tightly linked markers.
An autosomal recessive, genome-wide parametric linkage analysis was performed with Merlin, because male and female subjects appeared to be equally affected. Haplotypes inferred with Merlin were imported into Haplopainter. 18 Short Tandem Repeat Analysis of Family L-8600606. Short tandem repeat analysis was completed with 4 markers developed by the Cooperative Human Linkage Center and made available through Research Genetics Incorporated (Invitrogen, Carlsbad, California) according to a published method. 18 Markers with high heterozygosity were selected for this analysis.
Polymerase Chain Reaction and Sequencing. The TMC1 gene was amplified with previously reported gene-specific primers. 10 Amplification reactions were cycled by a standard protocol on a GeneMate Genius thermocycler (ISC BioExpress, Utah). Sequencing was completed with a BigDye v3.1 Terminator Cycle Sequencing kit (Applied Biosys-B A tems, Foster City, California) according to the manufacturer's instructions. Sequencing products were read with an ABI 3730s sequencer (Perkin Elmer, Waltham, Massachusetts). All sequencing chromatograms were compared to a published complementary DNA sequence; nucleotide changes were detected with Sequencher v4.5 (Gene Code Corporation, Ann Arbor, Michigan).
RESULTS
Clinical Data. In consanguineous Iranian family L-1651, two individuals received a diagnosis of ARNSHL (Fig 1) . Their hearing loss is congenital, moderate-to-profound across all frequencies, and stable over time. Variation in the severity of hearing impairment is apparent between individuals IV:3 and IV:5 (Fig 2A) . Individual IV:5 has profound hearing impairment across all frequencies that is typical of ARNSHL, whereas individual IV:3 has a significantly milder hearing impairment that is moderate at the higher frequencies.
Five individuals in consanguineous Iranian fami-ly L-8600606 received a diagnosis of ARNSHL ( Fig  1) . Audiometric data were available from 3 affected family members. Their hearing loss is congenital, profound across all frequencies, and stable over time ( Fig 2B) . Linkage Mapping. Genome-wide linkage analyses of GeneChip data from family L-1651 detected 511 Mendelian errors. Because of the small number of affected individuals, the highest parametric LOD (logarithm of odds) score was only 1.76. This score was obtained for a single region on chromosome 9 that spans approximately 12 cM and is flanked by markers SNP_A1744539 (rs4086590) and SNP_A-1673794 (rs10491841) at chromosomal position 9p11.2-p21.13 (43.4-79.2 Mb; Fig 3A) . Haplotype analysis revealed that the critical region coincided with the region identified in the linkage analysis ( Fig 3B) . The critical region overlaps the DFNB7/11 locus.
Short tandem repeat analysis using 4 highly polymorphic markers suggested that DFNB7/11 was also the likely disease locus for family L-8600606 on the Mutation Analysis. The entire coding region and splice sites of the TMC1 gene were sequenced in both families. In family L-1651, a previously reported homozygous splice site mutation (c.776+1G>A) was identified that changes the conserved 5' splice donor site of exon 7 from GT to AT ( Fig 4A) . This mutation segregated in the affected members of this family and has been shown to be absent in 100 Iranian control individuals. 10 In family L-8600606, we identified a novel homozygous 2-base pair deletion (c.1589-1590delCT) in exon 18 leading to a predicted frameshift that immediately introduces a premature stop codon (p.S530*; Fig 4B) . This mutation segregated in affected members of family L-8600606 and has been shown to be absent in 56 Iranian control individuals.
DISCUSSION
Our data provide further evidence that TMC1 mu- tations are common among ARNSHL cases worldwide. We report here the 31st recessive mutation in TMC1, c.1589-1590delCT, and the second incidence of the c.776+1G>A splice site mutation. These findings mean that mutations in TMC1 are the sixth most frequent cause of ARNSHL, only behind GJB2, SLC26A4, MYO15A, OTOF, and CDH23. 11 DFNB7/11 mutations also appear to be common in the consanguineous Iranian ARNSHL population, as a total of 6 Iranian DFNB7/11 cases have now been reported. 2, 10 The c.776+1G>A mutation in L-1651 was first reported in Iranian family M36. 10 It is therefore possible that this mutation arose as a founder effect in the Iranian population, because it accounts for one third of the DFNB7/11 cases reported in Iran and has not been observed elsewhere. Family L-1651 originates from the Yazd province in central Iran, whereas family M36 is from the Mashad province in northern Iran. Although these provinces are large and distinct, they are located adjacent to each other in northwestern Iran, providing the possibility of common ancestry between these families.
The alteration of the 5' splice donor site of exon 7 from a GT to an AT could lead to partial exon skipping, intron retention, or a significantly truncated transcript, depending on whether a cryptic splice site is used. 10 These possibilities have not been investigated, and RNA studies are not possible in this study, because we cannot obtain fresh peripheral blood samples. Individuals in family M36 were reported to have congenital, severe-to-profound hearing loss, 10 consistent with other DFNB7/11 families. An identical phenotype was observed for individual IV:5 (Fig 2A) in family L-1651 reported here. However, the hearing impairment of the other affected family member, IV:3 (Fig 2A) , was significantly less severe, in the moderate-to-severe range. In addition, the high-frequency hearing of individual IV:3 was much better preserved. High-frequency hearing loss is a hallmark of both DFNB7/11 and DFNA36 hearing loss. 9 Individual IV:3 also carries the c.776+1G>A mutation, and his milder phenotype may reflect an unidentified genetic modifier effect, which would be the first reported for a recessive TMC1 (DFNB7/11) mutation. Notably, this phenotypic variation was not reported in family M36, in which the equivalent mutation was found to segregate with hearing loss. 10 The novel indel mutation c.1589-1590delCT identified in Iranian family L-8600606 is predicted to lead to a frameshift and introduction of a premature stop codon (p.S530*), the consequence of which could be a shortened transcript that is susceptible to nonsense-mediated decay. If the transcript is resistant to nonsense-mediated decay, a severely truncated protein lacking the last 231 amino acid residues of the 760 amino acid TMC1 protein would be generated. The truncated protein would lack the last 2 predicted transmembrane domains, suggesting that its channel activity would be reduced or abolished. Unfortunately, we were also unable to investigate these possibilities by RNA or protein studies, because fresh peripheral blood samples are not available from our patients.
The milder hearing loss exhibited by individual IV:3 in family L-1651 may be the result of a genetic modifier. Such a modifier has not been reported for DFNB7/11 hearing impairment. Other possibilities are that the c.776+1G>A mutation does not completely abolish normal splicing of TMC1 or that the mutant transcript is not subject to nonsense-mediated decay and the truncated protein retains some residual function. This type of "leaky splicing" has been observed for other types of deafness, as well as DFNB7/11 (P. L. M. Huygen, unpublished observations). These effects are difficult to measure because of differential splicing of genes in different tissues. Even if we could obtain fresh blood samples from affected family members, it is possible that splicing of TMC1 is differentially regulated in lymphocytes compared to inner ear cells.
In summary, we have identified 2 new DFNB7/11 families in the Iranian population. Of these families, 1 segregates a novel mutation, and the other, a reported mutation in TMC1. In family L-1651, a possible genetic modifier effect is suggested by the milder hearing impairment in 1 person. The results of our study suggest that mutation at the DFNB7/11 locus is a common cause of ARNSHL in the Iranian population and that the c.776+1G>A mutation may have arisen because of a founder effect in this population.
